Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases

Radiofrequency of lung metastases below 4 cm, demonstrated an overall survival of 62 months, associated with a 4-year local efficacy of 89%. Repeatability of the technique allows a 4-year lung disease control rate of 44.1%, with patient retreated safely up to four times. Radiofrequency is an option for treatment of small size lung metastases, namely the ones below 2 to 3 cm in diameter.

[1]  W. Lees,et al.  Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases , 2013, CardioVascular and Interventional Radiology.

[2]  N. Ikeda,et al.  Prognostic Factors After Pulmonary Metastasectomy for Colorectal Cancer and Rationale for Determining Surgical Indications: A Retrospective Analysis , 2013, Annals of surgery.

[3]  C. Combescure,et al.  Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.

[4]  V. Brouste,et al.  Single-Session Radiofrequency Ablation of Bilateral Lung Metastases , 2012, CardioVascular and Interventional Radiology.

[5]  T. de Baère,et al.  Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. , 2011, Radiology.

[6]  M. Tsao,et al.  Pathologic assessment of radiofrequency ablation of pulmonary metastases. , 2010, Journal of vascular and interventional radiology : JVIR.

[7]  T. Chua,et al.  Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  H. Fernando,et al.  Surgical and nonresectional therapies for pulmonary metastasis. , 2010, The Surgical clinics of North America.

[9]  H. Hoffmann,et al.  Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  Carlo Bartolozzi,et al.  Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). , 2008, The Lancet. Oncology.

[11]  A. Ravaud,et al.  Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. , 2006, Radiology.

[12]  Young Hak Kim,et al.  Predictive factors for local recurrence of resected colorectal lung metastases. , 2005, The Annals of thoracic surgery.

[13]  Robert E Lenkinski,et al.  Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. , 2004, Radiology.

[14]  D. Morris,et al.  Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer , 2004, The British journal of surgery.

[15]  M. Mack,et al.  Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  P. McCormack,et al.  A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases. , 1998, Chest surgery clinics of North America.

[17]  W W Mayo-Smith,et al.  Percutaneous radiofrequency ablation of malignancies in the lung. , 2000, AJR. American journal of roentgenology.